Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Florida newborn screening for galactosemia.

T J DeClue1, J I Malone, T A Tedesco

  • 1University of South Florida, College of Medicine, Tampa.

The Journal of the Florida Medical Association
|June 1, 1991
PubMed
Summary

Galactosemia is a rare metabolic disorder affecting 1:50,000 newborns. Early diagnosis and treatment are crucial to prevent severe health issues and mortality in infants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.

Journal of diabetes and its complications·2001
Same author

Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial.

Diabetes care·2001
Same author

Management of hyperglycemic crises in patients with diabetes.

Diabetes care·2001
Same author

Therapeutic controversy: prevention and treatment of diabetes in children.

The Journal of clinical endocrinology and metabolism·2000
Same author

Diabetic cardiomyopathy and carnitine deficiency.

Journal of diabetes and its complications·1999
Same author

The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes.

Metabolism: clinical and experimental·1996

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Galactosemia is an inborn error of metabolism impacting galactose-1-phosphate conversion.
  • Untreated galactosemia leads to severe morbidity and mortality in newborns.
  • Newborn screening in Florida utilizes a fluorescence assay for galactose-1-phosphate uridyltransferase (GALT) activity.

Purpose of the Study:

  • To highlight the importance of newborn screening for galactosemia.
  • To discuss factors influencing GALT enzyme activity and screening results.
  • To emphasize the need for carrier detection and genetic counseling for at-risk families.

Main Methods:

  • Newborn screening via fluorescence assay measuring GALT activity in dried blood spots.
  • Analysis of genetic factors and external influences on enzyme activity.
  • Recommendations for carrier detection and genetic counseling.

Main Results:

  • Galactosemia screening identifies infants requiring immediate intervention.
  • Variability in GALT activity can complicate diagnosis.
  • Heterozygous infants and their parents are candidates for carrier testing.

Conclusions:

  • Early detection of galactosemia through newborn screening is vital for preventing severe outcomes.
  • Understanding factors affecting GALT activity is key for accurate diagnosis.
  • Genetic counseling and carrier detection are essential for families with galactosemia concerns.

Related Experiment Videos